Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Dual-listed on the NYSE and the Tel Aviv Stock Exchange, ICL is an industrial company focusing on agriculture, food, and engineered materials. The company is controlled by its largest shareholder, Tel Aviv-listed Israel Corporation. ICL employs more than 11,000 people, and its 2019 revenue totaled approximately $5.3 billion.
Israel Chemicals Donates Money, Swabs to Bolster Battle Against Covid-19 in Israel
×
Error: Contact form not found.
by Adi Pick / CTech
A medical worker wearing a protective mask and suit treats patients suffering from coronavirus disease (COVID-19) in an intensive care unit at the Oglio Po hospital in Cremona, Italy, March 19, 2020. Photo: Reuters / Flavio Lo Scalzo.
CTech – Tel Aviv-headquartered Israel Chemicals (ICL), with the help of the regional managers of its factories in China, is importing 20,000 swabs for the diagnosis of coronavirus (Covid-19) cases in Israel, the company announced Sunday. ICL also donated NIS 900,000 (approximately $247,000) to Israeli hospitals Soroka University Medical Center in Israel’s south and Chaim Sheba Medical Center in the Tel Aviv area.
The swabs, for which the company reported costs of NIS 200,000 (approximately $50,000), were pre-approved by Israel’s Ministry of Health.
